Search for: "Ranbaxy Laboratories, Inc."
Results 1 - 20
of 75
Sorted by Relevance
|
Sort by Date
8 Nov 2007, 8:01 pm
By Sherri Oslick -- Ranbaxy Laboratories, Astellas Pharma US, Inc., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]
18 Jun 2008, 4:39 am
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.Forbes gave a more complete account of the event, and noted an immediate drop in Ranbaxy stock of 5%:Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the… [read post]
8 Aug 2010, 8:32 pm
• Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
13 May 2010, 9:59 pm
By James DeGiulio -- Medicis Settles Solodyn Infringement Case with Ranbaxy Medicis Pharmaceutical Corp. has reached consent and licensing agreements with Ranbaxy Laboratories Inc., thus settling patent infringement claims against Ranbaxy over Medicis' oral acne drug Solodyn. [read post]
23 Nov 2012, 10:40 am
Indian drugmaker Ranbaxy Laboratories said it issued the recall because of its generic version of Pfizer Inc.'s Lipitor because after it learned that some lots of its 10-, 20- and 40-milligram doses of the drug may contain glass. [read post]
16 Jul 2010, 8:43 am
Power-One, Inc., 2008 WL 1734833, at *12 (E.D. [read post]
21 May 2013, 2:26 pm
Earlier this month, the Department of Justice announced a $500 million settlement it reached with Ranbaxy USA Inc., a subsidiary of the Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited. [read post]
13 May 2013, 7:58 am
Ranbaxy Laboratories, Ltd., et al. , Case No. [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]
30 Sep 2013, 8:12 am
Forest Laboratories, Inc. [read post]
8 Jul 2012, 1:58 pm
Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of generic versions of Lipitor, the best-selling drug in history. [read post]
18 Jun 2008, 12:41 pm
The Lipitor Scorecard has been updated, so go and have a look at the latest results - across 23 countries.For those keen on a little pharmaceutical patent blood sport, don't despair, the battle wages on in five European counries: Finland, Spain, Portugal, Denmark and RomaniaHere's the press release from Pfizer: Pfizer and Ranbaxy Settle Lipitor Patent Litigation (mostly) Worldwide Ranbaxy to Receive License in U.S. on November 30, 2011; NEW YORK--(BUSINESS WIRE)--Pfizer… [read post]
24 Dec 2008, 9:04 am
Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc. [read post]
17 Aug 2009, 8:01 am
On June 22, 2007, the Company received a civil investigative demand requesting that it provides information to the FTC relating to its settlement with Barr and its earlier settlement with Impax Laboratories, Inc. [read post]
17 Aug 2009, 8:01 am
On June 22, 2007, the Company received a civil investigative demand requesting that it provides information to the FTC relating to its settlement with Barr and its earlier settlement with Impax Laboratories, Inc. [read post]
16 Jul 2010, 7:14 am
Ranbaxy Laboratories Inc., 2-10-cv-00121 (TXED July 14, 2010, Report & Recommendations) (Everingham, M.J.) [read post]
21 Sep 2013, 6:55 pm
The Medicare fraud lawsuit is accusing LabCorp. of billing Medicaid fees way over what Premier Inc. purchasing collective members were charged. [read post]
16 Apr 2018, 2:48 pm
Ranbaxy Laboratories Ltd., Ranbaxy soughtto limit a claim depicting a specific three-dimensionalorientation to a racemic mixture. 457 F.3d 1284, 1288–89(Fed. [read post]
20 Feb 2014, 9:39 am
Ranbaxy Laboratories Ltd., 457 F.3d 1284 (Fed. [read post]
22 Jul 2011, 12:31 pm
Ranbaxy Laboratories, Inc., No. 10-793 (E.D. [read post]
